Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to compare the effects of FX006 and Triamcinolone Acetonide
Injectable Suspension, United States Pharmacopeia (USP) (referred to as TCA IR in the
protocol) on blood glucose (BG) in patients with osteoarthritis (OA) of the knee and Type 2
diabetes mellitus (DM).